Sun Pharma Advanced Research Company Limited has informed the Exchange about press release dated 09-Nov-2022 titled SPARC and Sun Pharma enter into a license agreement for commercialization of phenobarbital for injection in the US
Press Release Nov 09 2022
Filed with NSE ·
6ix hasn’t read this filing yet.
Sun Pharma Advanced Research Co. Ltd. on 6ix
Earlier from Sun Pharma Advanced Research
- Outcome of committee meeting
- Press Release Sep 29 2022
- AGM Speech 2021-22
- FY 2021-22
- Corporate Presentation
Later from Sun Pharma Advanced Research
- SEZABY™ (phenobarbital sodium powder for injection) approved by US FDA for the treatment of neonatal seizures
- Press Release Nov 18 2022
- Press Release Jul 13 2023
- AGM Speech 2022-23
- Press Release Oct 19 2023
Follow Sun Pharma Advanced Research into a list and get an email when it puts out news.
Follow Sun Pharma Advanced Research